Assessing and Management of Neurotoxicity After CAR-T Therapy in Diffuse Large B-Cell Lymphoma

Chimeric antigen receptor T-cell (CAR-T) therapy represents the most important advances in cancer immunotherapy, especially in hematological malignancies such as B-cell lymphomas. CAR-T cell therapy has significant activity in poor risk B-cell lymphomas. CAR-T cell therapy is associated with potenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Castaneda-Puglianini, Omar, Chavez, Julio C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403007/
https://www.ncbi.nlm.nih.gov/pubmed/34466048
http://dx.doi.org/10.2147/JBM.S281247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403007/
https://www.ncbi.nlm.nih.gov/pubmed/34466048
http://dx.doi.org/10.2147/JBM.S281247

Ejemplares similares